Tower Cancer Research Foundation

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 10 papers

  • Open Access
  • PDF
  • Research Article
  • Citations95

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts.

  • Oct 29, 2013
  • Journal of Hematology & Oncology
  • Moshe Talpaz +21
  • Open Access
  • PDF
  • Research Article
  • Citations85

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

  • Aug 25, 2013
  • Cancer Chemotherapy and Pharmacology
  • Kyriakos P Papadopoulos +11
  • Open Access
  • Research Article
  • Citations42

Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4–5 years

  • May 29, 2012
  • British Journal of Haematology
  • Carla E M Hollak +11
  • Research Article
  • Citations11

Preliminary safety and efficacy of ruxolitinib in patients (pts) with primary and secondary myelofibrosis (MF) with platelet counts (PC) of 50–100x10<sup>9</sup>/L.

  • May 20, 2012
  • Journal of Clinical Oncology
  • Moshe Talpaz +19
  • Open Access
  • Research Article
  • Citations13

Facet-sparing lumbar decompression with a minimally invasive flexible MicroBlade Shaver® versus traditional decompression: quantitative radiographic assessment

  • Jan 01, 2012
  • Clinical Interventions in Aging
  • Jon Block +6
  • Research Article
  • Citations735

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

  • Apr 15, 2010
  • New England Journal of Medicine
  • Ans T Van Der Ploeg +22
  • Abstract
  • Citations18

Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study.

  • Nov 20, 2009
  • Blood
  • Nathan Fowler +14
  • Open Access
  • Research Article
  • Citations35

The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia

  • Sep 07, 2007
  • Journal of Leukocyte Biology
  • Pavel Krejci +6
  • Abstract
  • Citations6

Active Immunotherapy with FavId® (Id/KLH) Following Rituximab Induction: Long-Term Follow-Up of Response Rate Improvement (RRI) and Disease Progression in Follicular Lymphoma Patients (pts).

  • Nov 16, 2006
  • Blood
  • Omer N Koc +15
  • Abstract

Phase II Study of Denileukin Diftitox (ONTAK®) in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) and Poor Bone Marrow Reserve.

  • Nov 16, 2006
  • Blood
  • Myron S Czuczman +9
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.